Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Leukemia Therapy
Scientists at McMaster University, Department of Medicine publish research in acute leukemia therapy
March 2nd, 2008
Research findings, 'A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation,' are discussed in a new report. "Anemia may be an important factor contributing to an increased risk of bleeding, particularly in patients with thrombocytopenia. A multicenter, single-blinded pilot randomized controlled trial (RCT) was performed to evaluate the feasibility of conducting a larger RCT to determine the effect of the hemoglobin (Hb) concentration on bleeding risk," researchers in Hamilton, Canada report. "Patients with acute...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-02)
|
